Potential Side Effects at 4 mg, 9 mg, and 12 mg TRANSCEND-T2D-1 reported nausea in 16.4%, 19.5%, and 26.5% of participants receiving 4 mg, 9 mg, and 12 mg, respectively, compared with 3.7% with placebo [9]
The medications large molecular size makes it unlikely to pass into milk in significant amounts, and even if it did, it would probably be destroyed in the infants digestive tract
For the most accurate estimates, refresh searches and enter your zip code
McMurray JJV, Solomon SD, Inzucchi SE, et al
PMID 34504426
16 In this study, the use of GLP-1 receptor agonists was associated with a lower risk for an alcohol-related event (hazard ratio [HR], 0.46